Context Therapeutics Receives Nasdaq Noncompliance Notice, Gets Time Through Jan. 25 To Regain Compliance
https://www.sec.gov/ix?doc=/Archives/edgar/data/1842952/000162828026051399/cntx-20260729.htm
Context Therapeutics got a warning that its stock price fell too low for Nasdaq rules, but the company has until January to fix it. This is a sign to watch whether the company can get its stock back up, or it might face removal from that exchange.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.